Related Experiment Videos

Corneal chromoblastomycosis

K Barton1, D Miller, S C Pflugfelder

  • 1Corneal and External Disease Service, Bascom Palmer Eye Institute, University of Miami School of Medicine, Florida, USA.

Cornea
|March 1, 1997
PubMed
Abstract

Insights

Managing rare, pigmented mold corneal ulcers is challenging. Systemic itraconazole combined with surgery offers the best treatment outcome for corneal chromoblastomycosis caused by Fonsecaea pedrosoi.

Area of Science:

  • Ophthalmology
  • Mycology

Background:

  • Corneal ulceration caused by pigmented molds, such as Fonsecaea pedrosoi, presents a diagnostic and therapeutic challenge.
  • Fonsecaea pedrosoi is the most common cause of cutaneous chromoblastomycosis, a chronic fungal infection.

Observation:

  • A patient with recurrent corneal infection due to Fonsecaea pedrosoi initially responded to antifungal treatment but relapsed.
  • Intraocular fungal infection was confirmed through cultures from fibrinous membranes during multiple surgical interventions.

Findings:

  • Despite initial medical therapy and therapeutic penetrating keratoplasty, the corneal infection recurred.
  • Aggressive surgical management including large penetrating keratoplasty and cataract extraction, followed by a 5-month course of systemic itraconazole, led to disease resolution.

Implications:

  • Corneal chromoblastomycosis caused by Fonsecaea pedrosoi is often resistant to standard medical therapy.
  • A combination of surgical intervention and systemic itraconazole appears to be the most effective treatment strategy for this challenging condition.

Related Concept Videos